Skip to main content
OpenTrials
Completed

NCT Number: NCT06133205

Efficacy of Abdominal Catgut Embedding Combined With Auricular Acupressure Therapy for Obese Patients

Objective: obesity is an important risk factor of chronic diseases, which not only threatens people's health, but also an important topic of public health. The purpose of this study is to define obesity according to the norms of the World Health Organization, and to explore whether combined weight loss methods have an impact on weight loss.

Methods:

In this study, Combined treatment of abdominal acupoint catgut embedding was combined with auricular pellet acupressure, The wire used for catgut embedding in the experiment was polydioxanone (PDO) 。 This experiment was divided into two groups: the experimental group A and the control group B 。 The reference measurement basis is the data obtained by "Inbody" instrument, including height and weight, body mass index (BMI), basic metallic rate (BMR), Body Fat Percentage BFP) , waist hip ratio and the data of total cholesterol (TC) and triglycerides (TG) obtained from biochemical blood examination, through the comparison before and after the test, we can judge whether the method of this test can achieve a certain degree of curative effect on weight loss.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acupuncture

Age range

25 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

China Medical University Hospital

Taichung, Taiwan

About this study

Objective: obesity is an important risk factor of chronic diseases, which not only threatens people's health, but also an important topic of public health. The purpose of this study is to define obesity according to the norms of the World Health Organization, and to explore whether combined weight loss methods have an impact on weight loss.

Methods:

In this study, This study is a random Single Blind Random Blind Trial conducted at Acupuncture and Moxibustion department of China Medical University hospital, Taichung city, Taiwan. The study involved 2 groups divided in 1:1 ratio to an intervention group and a control group. The study Combined treatment of abdominal acupoint catgut embedding was combined with auricular pellet acupressure, The wire used for catgut embedding in the experiment was polydioxanone (PDO) 。 This experiment was divided into two groups: the experimental group and the control group。The reference measurement basis is the data obtained by "Inbody" instrument, including height and weight, body mass index (BMI), basic metallic rate (BMR), Body Fat Percentage BFP), waist hip ratio and the data of total cholesterol (TC) and triglycerides (TG) obtained from biochemical blood examination, through the comparison before and after the test, we can judge whether the method of this test can achieve a certain degree of curative effect on weight loss.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

A. Age 25 to 45 years old B. In line with the World Health Organization's BMI standard diagnosis ≥ 25 C. Waist circumference of men ≥90 cm or waist circumference of women ≥80 cm D. Body fat rate of men>25%, body fat rate of women>30% E. The above B, C, D can be included if they meet one of them F. Complete written informed consent

Exclusion criteria

  • A. Pregnant, breastfeeding, menopausal women B. There are malignant tumors of the heart, liver and kidneys C. Diagnosed with mental illness D. Participated in another study within three months E. There are people who are taking diet pills

Treatment and study plan

Catgut Embedding at acupoints

Other

Supplemented by auricular point therapy, can increase the effect of catgut embedding therapy.

Primary outcomes

  1. body weight

    Time frame: 12 weeks

    body weight in kilograms measured at inclusion and at 12 weeks measured by "InBody" body analysis instrument

  2. BMI

    Time frame: 12 weeks

    Body mass index (BMI) measured at inclusion and at 12 weeks measured by "InBody" body analysis instrument

  3. basal metabolic rate

    Time frame: 12 weeks

    basal metabolic rate measured at inclusion and at 12 weeks measured by "InBody" body analysis instrument

  4. Body fat percentage

    Time frame: 12 weeks

    Body fat percentage measured at inclusion and at 12 weeks measured by "InBody" body analysis instrument

Secondary outcomes

  1. Triglycerides

    Time frame: 12 weeks

    Triglycerides levels in blood measured by blood tests on inclusion and at 12 weeks

  2. Total cholesterol

    Time frame: 12 weeks

    Total cholesterol levels in blood measured by blood tests on inclusion and at 12 weeks

  3. WHOQOL

    Time frame: 12 weeks

    WHOQOL numerical assessment of quality of life, fill in the questionnaire before the first treatment.

  4. Skeletal muscle weight

    Time frame: 12 weeks

    Skeletal muscle weight measured at inclusion and at 12 weeks measured by "InBody" body analysis instrument

  5. waist hip ratio

    Time frame: 12 weeks

    waist hip ratio measured at inclusion and at 12 weeks measured by "InBody" body

Sponsors and collaborators

Lead sponsor

China Medical University Hospital

Other

Registry information

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Nov 15, 2023
Registry last updated
Nov 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.